Works matching IS 20590105 AND DT 2020 AND VI 5 AND IP 1

Results: 113
    1
    2
    3
    4
    5

    Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00261-9
    By:
    • Roozendaal, Ramon;
    • Hendriks, Jenny;
    • van Effelterre, Thierry;
    • Spiessens, Bart;
    • Dekking, Liesbeth;
    • Solforosi, Laura;
    • Czapska-Casey, Dominika;
    • Bockstal, Viki;
    • Stoop, Jeroen;
    • Splinter, Daniel;
    • Janssen, Sarah;
    • Baelen, Ben van;
    • Verbruggen, Nadia;
    • Serroyen, Jan;
    • Dekeyster, Eline;
    • Volkmann, Ariane;
    • Wollmann, Yvonne;
    • Carrion, Ricardo;
    • Giavedoni, Luis D.;
    • Robinson, Cynthia
    Publication type:
    Article
    6

    Author Correction: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

    Published in:
    2020
    By:
    • Segura-Cerda, Cristian Alfredo;
    • Marquina-Castillo, Brenda;
    • Lozano-Ordaz, Vasti;
    • Mata-Espinosa, Dulce;
    • Barrios-Payán, Jorge Alberto;
    • López-Torres, Manuel O.;
    • de Jesús Aceves-Sánchez, Michel;
    • Bielefeldt-Ohmann, Helle;
    • Hernández-Pando, Rogelio;
    • Flores-Valdez, Mario Alberto
    Publication type:
    Correction Notice
    7
    8
    9
    10
    11

    Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00252-w
    By:
    • Blasi, Maria;
    • Negri, Donatella;
    • Saunders, Kevin O.;
    • Baker, Erich J.;
    • Stadtler, Hannah;
    • LaBranche, Celia;
    • Mildenberg, Benjamin;
    • Morton, Georgeanna;
    • Ciarla, Andrew;
    • Shen, Xiaoying;
    • Wang, Yunfei;
    • Rountree, Wes;
    • Balakumaran, Bala;
    • Santra, Sampa;
    • Haynes, Barton F.;
    • Moody, Anthony M.;
    • Cara, Andrea;
    • Klotman, Mary E.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-0169-6
    By:
    • Segura-Cerda, Cristian Alfredo;
    • Marquina-Castillo, Brenda;
    • Lozano-Ordaz, Vasti;
    • Mata-Espinosa, Dulce;
    • Barrios-Payán, Jorge Alberto;
    • López-Torres, Manuel O.;
    • Aceves-Sánchez, Michel de Jesús;
    • Bielefeldt-Ohmann, Helle;
    • Hernández-Pando, Rogelio;
    • Flores-Valdez, Mario Alberto
    Publication type:
    Article
    21
    22
    23
    24
    25

    Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00246-8
    By:
    • McAuley, Alexander J.;
    • Kuiper, Michael J.;
    • Durr, Peter A.;
    • Bruce, Matthew P.;
    • Barr, Jennifer;
    • Todd, Shawn;
    • Au, Gough G.;
    • Blasdell, Kim;
    • Tachedjian, Mary;
    • Lowther, Sue;
    • Marsh, Glenn A.;
    • Edwards, Sarah;
    • Poole, Timothy;
    • Layton, Rachel;
    • Riddell, Sarah-Jane;
    • Drew, Trevor W.;
    • Druce, Julian D.;
    • Smith, Trevor R. F.;
    • Broderick, Kate E.;
    • Vasan, S. S.
    Publication type:
    Article
    26
    27

    Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination.

    Published in:
    2020
    By:
    • Pejoski, David;
    • de Rham, Casimir;
    • Martinez-Murillo, Paola;
    • Santoro, Francesco;
    • Auderset, Floriane;
    • Medaglini, Donata;
    • Pozzi, Gianni;
    • Vono, Maria;
    • Lambert, Paul-Henri;
    • Huttner, Angela;
    • Haks, Mariëlle C.;
    • Ottenhoff, Tom H. M.;
    • Villard, Jean;
    • Siegrist, Claire-Anne;
    • the VEBCON Consortium;
    • Addo, Marylyn M.;
    • Agnandji, Selidji Todagbe;
    • Becker, Stephan;
    • Bejon, Philip;
    • Brosnahan, Jessica S.
    Publication type:
    Correction Notice
    28
    29

    Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00243-x
    By:
    • Bos, Rinke;
    • Rutten, Lucy;
    • van der Lubbe, Joan E. M.;
    • Bakkers, Mark J. G.;
    • Hardenberg, Gijs;
    • Wegmann, Frank;
    • Zuijdgeest, David;
    • de Wilde, Adriaan H.;
    • Koornneef, Annemart;
    • Verwilligen, Annemiek;
    • van Manen, Danielle;
    • Kwaks, Ted;
    • Vogels, Ronald;
    • Dalebout, Tim J.;
    • Myeni, Sebenzile K.;
    • Kikkert, Marjolein;
    • Snijder, Eric J.;
    • Li, Zhenfeng;
    • Barouch, Dan H.;
    • Vellinga, Jort
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00223-1
    By:
    • Martin, Jacob T.;
    • Cottrell, Christopher A.;
    • Antanasijevic, Aleksandar;
    • Carnathan, Diane G.;
    • Cossette, Benjamin J.;
    • Enemuo, Chiamaka A.;
    • Gebru, Etse H.;
    • Choe, Yury;
    • Viviano, Federico;
    • Fischinger, Stephanie;
    • Tokatlian, Talar;
    • Cirelli, Kimberly M.;
    • Ueda, George;
    • Copps, Jeffrey;
    • Schiffner, Torben;
    • Menis, Sergey;
    • Alter, Galit;
    • Schief, William R.;
    • Crotty, Shane;
    • King, Neil P.
    Publication type:
    Article
    40

    Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00221-3
    By:
    • Graham, Simon P.;
    • McLean, Rebecca K.;
    • Spencer, Alexandra J.;
    • Belij-Rammerstorfer, Sandra;
    • Wright, Daniel;
    • Ulaszewska, Marta;
    • Edwards, Jane C.;
    • Hayes, Jack W. P.;
    • Martini, Veronica;
    • Thakur, Nazia;
    • Conceicao, Carina;
    • Dietrich, Isabelle;
    • Shelton, Holly;
    • Waters, Ryan;
    • Ludi, Anna;
    • Wilsden, Ginette;
    • Browning, Clare;
    • Bialy, Dagmara;
    • Bhat, Sushant;
    • Stevenson-Leggett, Phoebe
    Publication type:
    Article
    41
    42

    Contagious Bovine and Caprine Pleuropneumonia: a research community's recommendations for the development of better vaccines.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00214-2
    By:
    • Jores, Joerg;
    • Baldwin, Cynthia;
    • Blanchard, Alain;
    • Browning, Glenn F.;
    • Colston, Angie;
    • Gerdts, Volker;
    • Goovaerts, Danny;
    • Heller, Martin;
    • Juleff, Nick;
    • Labroussaa, Fabien;
    • Liljander, Anne;
    • Muuka, Geoffrey;
    • Nene, Vish;
    • Nir-Paz, Ran;
    • Sacchini, Flavio;
    • Summerfield, Artur;
    • Thiaucourt, François;
    • Unger, Hermann;
    • Vashee, Sanjay;
    • Wang, Xiumei
    Publication type:
    Article
    43
    44

    A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00224-0
    By:
    • Lage, Daniela P.;
    • Ribeiro, Patrícia A. F.;
    • Dias, Daniel S.;
    • Mendonça, Débora V. C.;
    • Ramos, Fernanda F.;
    • Carvalho, Lívia M.;
    • de Oliveira, Daysiane;
    • Steiner, Bethina T.;
    • Martins, Vívian T.;
    • Perin, Luísa;
    • Machado, Amanda S.;
    • Santos, Thaís T. O.;
    • Tavares, Grasiele S. V.;
    • Oliveira-da-Silva, João A.;
    • Oliveira, Jamil S.;
    • Roatt, Bruno M.;
    • Machado-de-Ávila, Ricardo A.;
    • Teixeira, Antônio L.;
    • Humbert, Maria V.;
    • Coelho, Eduardo A. F.
    Publication type:
    Article
    45
    46
    47
    48

    Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00219-x
    By:
    • Müller, Helena;
    • Fehling, Sarah Katharina;
    • Dorna, Jens;
    • Urbanowicz, Richard A.;
    • Oestereich, Lisa;
    • Krebs, Yvonne;
    • Kolesnikova, Larissa;
    • Schauflinger, Martin;
    • Krähling, Verena;
    • Magassouba, N'Faly;
    • Fichet-Calvet, Elisabeth;
    • Ball, Jonathan K.;
    • Kaufmann, Andreas;
    • Bauer, Stefan;
    • Becker, Stephan;
    • von Messling, Veronika;
    • Strecker, Thomas
    Publication type:
    Article
    49

    A protective bivalent vaccine against Rift Valley fever and bluetongue.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00218-y
    By:
    • Calvo-Pinilla, Eva;
    • Marín-López, Alejandro;
    • Moreno, Sandra;
    • Lorenzo, Gema;
    • Utrilla-Trigo, Sergio;
    • Jiménez-Cabello, Luis;
    • Benavides, Julio;
    • Nogales, Aitor;
    • Blasco, Rafael;
    • Brun, Alejandro;
    • Ortego, Javier
    Publication type:
    Article
    50